Evidence map›Paper›PMID 42713239›Full record

ArticleCell surface (Amsterdam, Netherlands)2026

Non-ergosterol lipid remodeling governs amphotericin B susceptibility via TOR-calcineurin signaling in

Mohit Kumar, Sonam Kumari, Mohd Wasi, Basharat Ali, Praveen Kumar, Garvit Sharma, Ashutosh Singh, Alessandra da Silva Dantas, Neil A R Gow, Naseem A Gaur and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell surface (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohit KumarInternational Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Sonam KumariIndian Council of Medical Research, New Delhi, India.
Mohd WasiInternational Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Basharat AliAmity Institute of Biotechnology, Amity University Gurgaon, Haryana, India.
Praveen KumarAmity Institute of Biotechnology, Amity University Gurgaon, Haryana, India.
Garvit SharmaInternational Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Ashutosh SinghDepartment of Biochemistry, University of Lucknow, India.
Alessandra da Silva DantasSchool of Dental Sciences. Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4BW, UK.
Neil A R GowMedical Research Council Centre for Medical Mycology, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter EX4 4QD, UK.
Naseem A GaurInternational Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Rajendra PrasadAmity Institute of Biotechnology, Amity University Gurgaon, Haryana, India.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Understanding the molecular determinants of antifungal drug susceptibility is essential for addressing rising resistance in fungal pathogens. Here, we uncover a central role for sphingolipid (SL) metabolism in modulating susceptibility to amphotericin B (AmB) in

Indexed as

Amphotericin BCalcineurinCandida glabrataCgIsc1SphingolipidsTOR pathway

Identifiers

PMID42713239
PMCPMC13551935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.